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We investigated the mechanism of lymphocyte infiltration into tissues infected with human T-cell leukemia virus type 1
(HTLV-1). The cytokine SDF-1/PBSF is a highly efficient chemoattractant for lymphocytes. Reverse transcription–PCR analysis
showed that among various human T-cell lines, those infected with HTLV-1 selectively expressed the SDF-1 gene. Expression
of the viral protein Tax in a human T-cell line induced the expression of the SDF-1 gene, indicating that the constitutive
expression of SDF-1 in virus-infected cell lines is at least in part mediated by Tax. HTLV-1-infected T-cell lines also expressed
CXCR-4, a receptor for SDF-1. Moreover, chemotaxis assay showed that a HTLV-1-infected cell line migrated toward synthetic
SDF-1. Thus, HTLV-1-infected cells are themselves responders for SDF-1. Our results suggest that SDF-1 induced by Tax may
alter the distribution of HTLV-1-infected cells in vivo; hence it may contribute to their infiltration into affected tissues in
HTLV-1-associated inflammatory diseases. © 1998 Academic Press
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INTRODUCTION
Human T-cell leukemia virus type 1 (HTLV-1) is an
etiologic agent for adult T-cell leukemia and other
chronic inflammatory diseases such as HTLV-1-associ-
ated myelopathy/tropical spastic paraparesis (HAM/TSP)
and HTLV-1-associated uveitis (HU) (Hinuma et al., 1981;
Poiesz et al., 1980; Gessain et al., 1985; Osame et al.,
1986; Mochizuki et al., 1992). A characteristic feature of
these HTLV-1-associated diseases is infiltration of lym-
phocytes including virus-infected cells into affected tis-
sues, such as eyes and central nervous system (Kira et
al., 1992). Infiltration of virus-infected cells may, thus, play
a role in the development of these diseases.
In addition to the structural genes, HTLV-1 encodes a
regulatory gene tax. Interestingly, mice and rats carrying
HTLV-1 tax or tax/env transgenes develop various inflam-
matory diseases such as arthritis, dermatitis, and polyar-
teritis (Green et al., 1989; Iwakura et al., 1991; Yamazaki
et al., 1997). Tax is a transcriptional activator for the viral
gene and a number of cellular genes (Uchiyama, 1997;
Yoshida, 1995). Thus, dysregulated cellular gene expres-
sion by Tax may be involved in the development of
HTLV-1-associated inflammatory diseases.
Chemotactic cytokines (chemokines) are thought to
play a major role in the migration of cells from one tissue
to another, thereby controlling cell migration during in-
flammation (Baggiolini et al., 1997). Chemokines consist
of a large family of cytokines. Each family member has a
different activity toward different types of cells. For ex-
ample, interleukin (IL)-8 is a highly efficient chemoattrac-
tant for monocytes and neutrophils, but not for lympho-
cytes (Baggiolini et al., 1994). SDF-1/PBSF (stromal cell-
derived factor-1/pre-B-cell growth-stimulating factor) is a
highly efficient chemoattractant for lymphocytes and
monocytes but not for neutrophils (Tashiro et al., 1993;
Bleul et al., 1996b; Nagasawa et al., 1996).
In the present study, we show that among various
human T-cell lines, those infected with HTLV-1 preferen-
tially express SDF-1, and the expression is at least in part
mediated by Tax. We also discuss these findings in the
context of lymphocyte infiltration into tissues affected in
HTLV-1-associated inflammatory diseases.
RESULTS
RNA was prepared from eight human T-cell lines (Ta-
ble 1), and the expression of the SDF-1 gene in these
cells was examined by the reverse transcription (RT)–
PCR method. Three (MT-2, HUT102, and TL-Su,) of five
HTLV-1-infected T-cell lines expressed SDF-1 RNA, but
the latter was not expressed in all three uninfected T-cell
lines (Fig. 1). DNA sequence analysis of fragments am-
plified by SDF-1 primers confirmed that it was derived
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from the SDF-1 RNA. Thus, HTLV-1-transformed T-cell
lines preferentially expressed SDF-1.
The HTLV-1 Tax protein activates the expression of a
number of cellular genes (Yoshida, 1995). Thus, we next
measured the expression of Tax in these T-cell lines by
Western blot analysis. The HTLV-1-transformed cell lines,
except MT-1 and TL-OmI, expressed 40 kDa protein
corresponding to Tax (Fig. 2). Since neither MT-1 nor
TL-OmI expressed SDF-1, the expression of Tax corre-
lated with that of SDF-1 in these HTLV-1-infected T-cell
lines (Table 1). Anti-Tax antibody also detected several
other proteins migrating around 68 kDa (MT-2) and 36
kDa (TL-Su). These proteins are probably derived from
chimerical tax genes (Kobayashi et al., 1984).
To examine the role of Tax in the expression of the SDF-1
gene, we used JPX-9, which is a derivative of Jurkat and has
a tax cDNA under the control of the inducible methalothio-
nein promoter (Fig. 3; Ohtani et al., 1989). The addition of
CdCl2 (10 mM/ml) to the culture medium of JPX-9 induced
the expression of Tax within 3 days, which persisted until 9
days after treatment. JPX-9 increased the expression of
SDF-1 within 6 days of treatment with CdCl2, and it was
further enhanced 9 days after the treatment. The induction
of SDF-1 was due to Tax but not by CdCl2 treatment, since
it was not observed in JPX/M expressing the nonfunctional
Tax protein following treatment with CdCl2. These results
indicate that Tax is, at least in part, responsible for the
constitutive expression of the SDF-1 gene in HTLV-1-trans-
formed cells.
We also examined whether HTLV-1-transformed T-cell
lines express CXCR-4 a receptor for SDF-1 (Bleul et al.,
1996a; Oberlin et al., 1996). Flow cytometer analysis
using an anti-CXCR-4 antibody showed that all examined
T-cell lines expressed CXCR-4 (Fig. 4). The expression of
CXCR-4 protein on HTLV-1-infected T-cell lines was less
than that of three HTLV-1-uninfected cell lines.
Next we examined the SDF-1-induced chemotactic
activity of the HTLV-1-infected T-cell line, MT-2. Human
peripheral blood mononuclear cells (PBMC) preactivated
with PHA and IL-2 were used as control. A Transwell cell
migration assay using a 12-mm pore polycarbonate
membrane showed that MT-2 cells migrated toward
SDF-1 in a dose-dependent manner (Fig. 5A). The migra-
tion of MT-2 is specific to SDF-1, since bovine serum
albumin used as a control protein did not change the
chemotactic activity of MT-2 cells. The migration of MT-2
toward SDF-1 at the concentration of 10 or 100 nM and
1000 nM was less and more than activated PBMC, re-
spectively (Fig. 5). It is, however, difficult to compare the
efficiency, since the cell size of MT-2 and the size of the
used membrane pore are different from those in acti-
TABLE 1
Phenotypes of T-Cell Lines Used in the Present Study
Cell line
HTLV-1
provirus
Tax
protein
SDF-1
RNA
TL-Oml 1 2 2
MT-1 1 2 2
MT-2 1 1 1
TL-Su 1 1 1
HUT102 1 1 1
CCRF-CEM 2 2a 2
Jurkat 2 2 2
MOLT-4 2 2 2
a See Sugamura et al., (1984).
FIG. 1. SDF-1 gene expression in HTLV-1-infected T-cell lines. RNA
was prepared from indicated cell lines, and the expression of SDF-1 in
each cell line was measured by RT-PCR analysis. The PCR-amplified
fragments separated by a polyacrylamide gel were analyzed by a
sequencer, and the gel image is presented. SDF-1/b-actin indicates the
amplified SDF-1 fragment relative to that of b-actin. Data are a repre-
sentative example of three reproducible experiments.
FIG. 2. Expression of the Tax protein in HTLV-1-infected T-cell lines.
Cell lysate was prepared from the indicated cell lines, and the amount
of Tax in each lysate was measured by Western blot analysis using an
anti-Tax antibody (Lt-4). Marker (lane 1) is a molecular weight marker.
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vated PBMC. Taken together, these results indicated that
HTLV-1-infected T-cell lines can efficiently migrate to-
ward SDF-1 at least in vitro.
DISCUSSION
Infiltration of lymphocytes, including virus-infected
cells, into affected tissues such as the eyes and central
nervous system is commonly observed in HTLV-1-asso-
ciated inflammatory diseases and may be a critical step
in the development of the disease (Uchiyama, 1997). The
major findings of the present study were: (i) the expres-
sion of SDF-1 in HTLV-1-infected T-cell lines (Fig. 1); (ii)
that the viral protein Tax is responsible for the expres-
sion of SDF-1 (Fig. 2); and (iii) the expression of CXCR-4
and chemotactic response toward SDF-1 of a HTLV-1-
infected T-cell line. SDF-1 is a highly efficient chemoat-
tractant for lymphocytes both in vitro and in vivo (Bleul et
al., 1996b). Thus, SDF-1 induced by Tax may be a factor
responsible for infiltration of lymphocytes into tissues
affected in HTLV-1-associated inflammatory diseases
such as HAM/TSP and HU (Yoshida, 1995; Uchiyama,
1997).
In addition to SDF-1, Tax is known to induce the ex-
pression of several chemokine genes, such as MIP-1a,
MIP-1b, and IL-8 (Baba et al., 1996; Mori et al., 1995).
Thus, these chemokines may also play a role in the
pathophysiology of HTLV-1-associated diseases. It
should, however, be noted that SDF-1 is the most effi-
cient chemoattractant for lymphocytes in vitro as well as
in vivo among the chemokines identified to date (Bleul et
al., 1996b). Thus, SDF-1 is a valid candidate for explain-
ing the infiltration of lymphoid cells into HTLV-1-affected
tissues.
Chemokines are not the only determinant of lympho-
cyte accumulation into inflammatory tissues; cell adhe-
sion molecules are also involved in this process (Uch-
iyama, 1997). Interestingly, Tax also activates the expres-
sion of genes encoding several cell adhesion molecules
such as E-cadherin and ICAM-1 (Kitajima et al., 1996;
Fukudome et al., 1992). Thus, the combined action of
multiple cellular genes including SDF-1 may promote
lymphocyte infiltration into affected tissues in HTLV-1-
associated diseases.
In addition to its action as a chemoattractant, SDF-
1/PBSF acts as a growth-stimulating factor for pre-B-
cells (Nagasawa et al., 1996). Tax-induced SDF-1 may,
thus, affect the proliferation and/or differentiation of
B-cells in vivo. In this regard, anti-DNA or anti-immu-
noglobulin antibodies have been detected in the sera
of patients with HTLV-1-associated diseases (Osame
et al., 1987; Usuku et al., 1988), and elevated levels of
secreted immunoglobulin and abnormal B-cell expan-
sion are present in transgenic mice carrying tax
(Peebles et al., 1995). Thus, SDF-1 may be a factor
responsible for these B-cell abnormalities in HTLV-1-
infected individuals.
FIG. 3. Tax induces SDF-1 gene expression in a T-cell line. (A) JPX-9 and JPX/M were cultured in the presence of CdCl2 (10 mM) at 37°C for 0–9
days. The cell lysate was prepared from these cells, and the amount of Tax was measured by Western blotting analysis. (B) JPX-9 and JPX/M were
cultured in the presence of CdCl2 (10 mM) at 37°C for 0–9 days. RNA was extracted from these cells, and the expression of the SDF-1 in the extracted
RNA was analyzed by RT-PCR analysis. The amplified fragments separated by polyacrylamide gel were analyzed by a sequencer, and the gel image
is presented. SDF-1/b-actin indicates the amplified SDF-1 fragment relative to that of b-actin. Data are representative examples of three reproducible
experiments.
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The expression of the genes of several chemokines,
including MIP-1a, MIP-1b, and IL-8, is low or undetect-
able in many tissues including PBMC. These genes are
induced by stimulation with mitogens in PBMC (Baggio-
lini et al., 1997). In contrast, SDF-1 is constitutively ex-
pressed in several tissues (Tashiro et al., 1993). How-
ever, we observed that PBMC expressed SDF-1 only
after stimulation with mitogen (data not shown). Thus,
inducible SDF-1 in normal PBMC may play a role in
lymphocyte migration during immune reaction.
MATERIALS AND METHODS
Cell lines
Human T-cell lines used in the present study have
been characterized previously (Sugamura et al., 1984).
TL-Su, MT-2, MT-1, TL-OmI, and HUT102 are HTLV-1-
transformed T-cell lines. Jurkat, MOLT-4, and CCRF-CEM
are HTLV-1-negative human T-cell lines. JPX-9 and JPX-
9/M cells are derivatives of Jurkat and have a stably
integrated tax and tax mutant gene under the control of
a methallothionein promoter, respectively (Ohtani et al.,
1989). To determine the expression of Tax, the cells were
cultured in the presence of CdCl2 (10 mM) at 37°C for 0–9
days. They were cultured in RPMI 1640 medium supple-
mented with 10% FCS (RPMI/FCS).
Western blotting analysis
Cell lysate was prepared from T-cell lines, and the
proteins in these lysates were resolved by electrophore-
sis on discontinuous 10% polyacrylamide gels with so-
dium dodecyl sulfate. They were then transferred to
PVDF membranes. The blots were incubated with anti-
Tax antibody, then rinsed and incubated with anti-mouse
immunoglobulin conjugated with horseradish peroxi-
dase. Sites of antibody binding were visualized using the
ECL Western blotting detection system (Amersham). An-
ti-Tax antibody (Lt-4) is a mouse monoclonal antibody,
FIG. 4. Expression of CXCR-4 on human T-cell lines. Cells were treated with anti-CXCR-4 antibody (IVR7) for 1 h on ice. Subsequently, they were
treated with anti-mouse immunoglobulin labeled with PE. The cells were then analyzed on a flow cytometer.
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which was kindly provided by Dr. Y. Tanaka of Kitasato
University (Lee et al., 1989).
RT-PCR analysis
RNA was extracted from T-cell lines according to the
Isogen method described previously by Chomczynski
(1993). For RT-PCR analysis, rTth DNA polymerase with
reverse transcriptase activity was used for reverse tran-
scription and sequential PCR in the presence of sense
and antisense primer (Perkin–Elmer). Primers used for
the amplification of SDF-1 and b-actin were CCGCG-
CTCTGCCTCAGCGACGGGAAG (sense primer), CTTGTT-
TAAAGCTTTCTCCAGGTACT (antisense primer), and AA-
GAGAGGCATCCTCACCCT (sense primer), TAGATGGCT-
GGGGTGTTGAA 39 (antisense primer), respectively. The
sense primer for SDF-1 and b-actin was labeled with
6-carboxyfluorescein (6-FAM) and 4,7,29,79-tetrachloro-6-
carboxyfluorescein (TET), respectively. The amount of the
expected 218-bp (b-actin) and 227-bp fragments (SDF-1)
was quantitated by measuring their absorbency at 532
nm (6-FAM) and at 543 nm (TET) with a sequencer
(Prisom 377; Applied Biosystems) according to the in-
structions provided by the manufacturer. The relative
amount of SDF-1 RNA represented the amount of SDF-1
fragment relative to that of b-actin after amplification.
Flow cytometry
T-cell lines were incubated with 100 ng/ml of IVR7
antibody against human CXCR-4 for 1 h on ice. After
washing, the cells were further incubated with an anti-
mouse immunoglobulin labeled with phycoerythrin (PE).
In the next step, the cells were washed and analyzed on
a FACSCalibur (Becton Dickinson). IVR7 antibody was
provided by Dr. T. Uchiyama (Institute for Virus Research,
Kyoto University)(T. Hori et al., submitted for publication).
Chemotaxis assay
SDF-1 was synthesized as described (Bleul et al.,
1996a) and kindly provided by N.Fujii and H.Tamamura
(Kyoto University, Kyoto, Japan). For the preparation of
activated PBMC, human PBMC were isolated from blood
of healthy donors by centrifugation on Ficoll–Paque and
cultured in RPMI/FCS with 1% phytohemagglutinin for 2
days. After washing PBMC were further cultured in
RPMI/FCS with recombinant interleukin 2 (2 ng/ml) for 7
days. The chemotaxis assay was carried out as de-
scribed (Bleul et al., 1996b). Briefly, 5 3 105 MT-2 cells or
1 3 106 preactivated PBMC were washed with PBS and
suspended in RPMI 1640 containing 0.25% human serum
albumin. They were then added to the top chamber of a
12-mm (for MT-2) or 5-mm (for PBMC) pore polycarbonate
Transwell culture insert (Costar, Cambridge, MA), the
bottom chamber of which had SDF-1 or bovine serum
albumin as control protein. The cells were then cultured
at 37°C for 3 h, and then the number of cells that
transmigrated into the lower chamber was counted by
trypan blue exclusion.
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